UPDATE: On May 20, 2021, CMS Announced that the 2020 Cost Performance Category will not be calculated for 2020 and the category will be reweighted according the previous finalized guidance. For anesthesiologists, this most likely means the 15% cost performance category will be reweighted to the MIPS Quality performance category.
For the 2020 performance year, eligible clinicians will receive a Cost performance category score that accounts for 15% of their final MIPS score.
ECs and groups do not need to submit data or attest to anything for this category. Instead, CMS uses claims data to assess an individual or group's performance during the performance year.
In 2020, CMS will use claims data to assess individual ECs and their groups on the following twenty (20) cost measures. Attribution of individual ECs or groups to these measures is often dependent upon the plurality of services and costs provided to individual patients for these measures. If an EC or group is unable to be scored in the Cost category, the 15% weighting will be redistributed to the Quality performance category. Visit the ASA Cost performance category FAQs for more information.
Population-based cost measures:
Procedural episode-based cost measures:
Acute inpatient medical condition episode-based cost measures:
Cost measure specifications and regulatory information are available on the Quality Payment Program Resource Library website. ASA continues to advocate for physician anesthesiologists to be fairly and accurately assessed under the MIPS cost category.